BSE Live
Feb 13, 16:01Prev. Close
1739.65
Open Price
1706.15
Bid Price (Qty.)
1722.55 (1)
Offer Price (Qty.)
1736.80 (4)
NSE Live
Feb 13, 15:45Prev. Close
1736.80
Open Price
1729.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1731.20 (4)
| Key Financial Ratios of Caplin Point Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 44.67 | 37.36 | 30.89 | 24.82 | 20.65 | |
| Diluted EPS (Rs.) | 44.47 | 37.18 | 30.62 | 24.60 | 20.45 | |
| Cash EPS (Rs.) | 47.93 | 40.92 | 34.24 | 28.18 | 23.62 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 223.81 | 183.03 | 150.19 | 122.78 | 100.30 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 223.81 | 183.03 | 150.19 | 122.78 | 100.30 | |
| Dividend / Share(Rs.) | 6.00 | 5.00 | 4.50 | 4.00 | 3.00 | |
| Revenue from Operations/Share (Rs.) | 99.00 | 82.30 | 69.65 | 69.66 | 63.81 | |
| PBDIT/Share (Rs.) | 61.39 | 51.73 | 42.02 | 36.43 | 30.74 | |
| PBIT/Share (Rs.) | 58.13 | 48.17 | 38.64 | 33.03 | 27.78 | |
| PBT/Share (Rs.) | 58.11 | 48.16 | 38.62 | 33.02 | 27.75 | |
| Net Profit/Share (Rs.) | 44.67 | 37.35 | 30.86 | 24.78 | 20.65 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 62.00 | 62.85 | 60.33 | 52.29 | 48.17 | |
| PBIT Margin (%) | 58.71 | 58.52 | 55.47 | 47.41 | 43.52 | |
| PBT Margin (%) | 58.70 | 58.50 | 55.45 | 47.40 | 43.49 | |
| Net Profit Margin (%) | 45.12 | 45.38 | 44.31 | 35.57 | 32.36 | |
| Return on Networth / Equity (%) | 19.95 | 20.40 | 20.55 | 20.18 | 20.59 | |
| Return on Capital Employed (%) | 25.76 | 26.07 | 25.36 | 26.21 | 26.81 | |
| Return on Assets (%) | 18.71 | 18.63 | 17.97 | 17.82 | 18.14 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 0.45 | 0.44 | 0.45 | 0.55 | 56.06 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 8.27 | 5.89 | 4.52 | 6.13 | 6.89 | |
| Quick Ratio (X) | 7.61 | 5.17 | 4.17 | 5.69 | 6.57 | |
| Inventory Turnover Ratio (X) | 9.87 | 2.50 | 3.21 | 4.61 | 19.41 | |
| Dividend Payout Ratio (NP) (%) | 11.19 | 12.04 | 12.94 | 0.00 | 1.93 | |
| Dividend Payout Ratio (CP) (%) | 10.42 | 10.99 | 11.66 | 0.00 | 1.69 | |
| Earnings Retention Ratio (%) | 88.81 | 87.96 | 87.06 | 0.00 | 98.07 | |
| Cash Earnings Retention Ratio (%) | 89.58 | 89.01 | 88.34 | 0.00 | 98.31 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 15,005.05 | 9,789.11 | 4,257.57 | 4,837.56 | 2,691.63 | |
| EV/Net Operating Revenue (X) | 19.94 | 15.66 | 8.05 | 9.16 | 5.58 | |
| EV/EBITDA (X) | 32.16 | 24.91 | 13.35 | 17.52 | 11.57 | |
| MarketCap/Net Operating Revenue (X) | 20.23 | 16.01 | 8.57 | 9.76 | 6.33 | |
| Retention Ratios (%) | 88.80 | 87.95 | 87.05 | 0.00 | 98.06 | |
| Price/BV (X) | 8.95 | 7.20 | 3.97 | 5.54 | 4.03 | |
| Price/Net Operating Revenue | 20.23 | 16.01 | 8.57 | 9.76 | 6.33 | |
| Earnings Yield | 0.02 | 0.03 | 0.05 | 0.04 | 0.05 |
10.02.2026
Caplin Labs Consolidated December 2025 Net Sales at Rs 542.77 crore, up 10.1% Y-o-Y
09.02.2026
Caplin Labs Standalone December 2025 Net Sales at Rs 189.22 crore, up 2.15% Y-o-Y
12.11.2025
Caplin Labs Standalone September 2025 Net Sales at Rs 175.18 crore, down 15.75% Y-o-Y
05.11.2025
Caplin Labs Consolidated September 2025 Net Sales at Rs 534.04 crore, up 10.54% Y-o-Y